NEXUS PHARMS FDA Approval ANDA 204860

ANDA 204860

NEXUS PHARMS

FDA Drug Application

Application #204860

Application Sponsors

ANDA 204860NEXUS PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 5MG BASE/ML0PROCHLORPERAZINE EDISYLATEPROCHLORPERAZINE EDISYLATE

FDA Submissions

UNKNOWN; ORIG1AP2019-02-15STANDARD

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAP

CDER Filings

NEXUS PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204860
            [companyName] => NEXUS PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PROCHLORPERAZINE EDISYLATE","activeIngredients":"PROCHLORPERAZINE EDISYLATE","strength":"EQ 5MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/15\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-02-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.